Literature DB >> 1739701

Treatable blindness in temporal arteritis.

L Clearkin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1739701      PMCID: PMC504159          DOI: 10.1136/bjo.76.1.63

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  6 in total

1.  Progressive anterior ischemic optic neuropathy due to giant cell arteritis despite high-dose intravenous corticosteroids.

Authors:  M L Slavin; A J Margolis
Journal:  Arch Ophthalmol       Date:  1988-09

2.  Sudden death following high-dose intravenous methylprednisolone.

Authors:  J F Thompson; D H Chalmers; R F Wood; S R Kirkham; P J Morris
Journal:  Transplantation       Date:  1983-11       Impact factor: 4.939

3.  Reversal of blindness in temporal arteritis with methylprednisolone.

Authors:  D G Model
Journal:  Lancet       Date:  1978-02-11       Impact factor: 79.321

4.  Treatment of temporal arteritis with ocular involvement.

Authors:  S I Rosenfeld; G S Kosmorsky; T G Klingele; R M Burde; E M Cohn
Journal:  Am J Med       Date:  1986-01       Impact factor: 4.965

5.  Treatable blindness in temporal arteritis.

Authors:  J P Diamond
Journal:  Br J Ophthalmol       Date:  1991-07       Impact factor: 4.638

6.  Prognosis in giant-cell arteritis.

Authors:  E Graham; A Holland; A Avery; R W Russell
Journal:  Br Med J (Clin Res Ed)       Date:  1981-01-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.